The following Corporate Crime guidance note Produced in partnership with 25 Bedford Row provides comprehensive and up to date legal information covering:
The Psychoactive Substances Act 2016 (PSA 2016) received Royal Assent on 1 February 2016. Originally, the provisions were set to come into force on 6 April 2016, however, following concerns over the enforcement of the provisions, implementation was delayed until 26 May 2016.
Since 2008/2009 the UK has seen increased usage and development of substances that mimic the effects of drugs regulated under the Misuse of Drugs Act 1971 (MDA 1971). It is accepted that these substances are difficult to identify and change on a frequent basis, making them difficult to regulate. They also pose a considerable threat to public health. The Prison and Probation Ombudsman and Chief Inspector of Prisons both expressed their concerns about the use of psychoactive substances in custodial institutions on the lead up to the introduction of this piece of legislation.
In order for a drug to be controlled under MDA 1971, it must undergo a period of assessment by the Advisory Council on the Misuse of Drugs, which will consider what physical and social harms a drug may have. More recently, temporary class drug orders were introduced in 2011 with the aim of reducing the amount of time required to control new substances. Notwithstanding that, the classification of new drugs under MDA 1971 remains a time-consuming and expensive process requiring parliamentary approval.
Following a review
**Trials are provided to all LexisPSL and LexisLibrary content, excluding Practice Compliance, Practice Management and Risk and Compliance, subscription packages are tailored to your specific needs. To discuss trialling these LexisPSL services please email customer service via our online form. Free trials are only available to individuals based in the UK. We may terminate this trial at any time or decide not to give a trial, for any reason. Trial includes one question to LexisAsk during the length of the trial.
To view the latest version of this document and thousands of others like it, sign-in to LexisPSL or register for a free trial.
Existing user? Sign-in
Take a free trial
0330 161 1234
To view our latest legal guidance content,sign-in to Lexis®PSL or register for a free trial.